Akero Therapeutics Stock Price History
| AKRO Stock | USD 32.18 0.98 3.14% |
Below is the normalized historical share price chart for Akero Therapeutics extending back to June 20, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Akero Therapeutics stands at 32.18, as last reported on the 22nd of November, with the highest price reaching 32.17 and the lowest price hitting 29.97 during the day.
If you're considering investing in Akero Stock, it is important to understand the factors that can impact its price. Akero Therapeutics appears to be very steady, given 3 months investment horizon. Akero Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0826, which signifies that the company had a 0.0826% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Akero Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Akero Therapeutics' mean deviation of 2.34, and Risk Adjusted Performance of 0.0826 to double-check if our risk estimates are consistent with your expectations.
At this time, Akero Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 22nd of November 2024, Liabilities And Stockholders Equity is likely to grow to about 609.3 M, while Common Stock Total Equity is likely to drop 2,933. . At this time, Akero Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 22nd of November 2024, Price To Book Ratio is likely to grow to 2.41, while Price Earnings Ratio is likely to drop (8.49). Akero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of June 2019 | 200 Day MA 25.2757 | 50 Day MA 29.7333 | Beta (0.26) |
Akero |
Sharpe Ratio = 0.0826
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AKRO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.06 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Akero Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akero Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.8961 | Book Value 10.606 | Enterprise Value 1.5 B | Enterprise Value Ebitda (6.77) | Shares Float 55.4 M |
Akero Therapeutics Stock Price History Chart
There are several ways to analyze Akero Stock price data. The simplest method is using a basic Akero candlestick price chart, which shows Akero Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 6, 2024 | 35.28 |
| Lowest Price | September 11, 2024 | 25.62 |
Akero Therapeutics November 22, 2024 Stock Price Synopsis
Various analyses of Akero Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Akero Stock. It can be used to describe the percentage change in the price of Akero Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Akero Stock.| Akero Therapeutics Price Rate Of Daily Change | 1.03 | |
| Akero Therapeutics Price Action Indicator | 1.60 | |
| Akero Therapeutics Price Daily Balance Of Power | 0.45 |
Akero Therapeutics November 22, 2024 Stock Price Analysis
Akero Stock Price History Data
The price series of Akero Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 9.66 with a coefficient of variation of 8.09. The prices are distributed with arithmetic mean of 29.01. The median price for the last 90 days is 28.69.| Open | High | Low | Close | Volume | ||
11/22/2024 | 31.20 | 32.17 | 29.97 | 32.17 | ||
| 11/21/2024 | 30.88 | 31.27 | 29.97 | 31.20 | 534,908 | |
| 11/20/2024 | 30.72 | 31.60 | 29.88 | 30.64 | 539,077 | |
| 11/19/2024 | 29.34 | 31.10 | 29.10 | 31.03 | 800,232 | |
| 11/18/2024 | 28.72 | 29.85 | 28.44 | 29.56 | 1,204,556 | |
| 11/15/2024 | 29.97 | 30.01 | 27.05 | 28.09 | 1,099,151 | |
| 11/14/2024 | 30.83 | 31.43 | 29.53 | 29.76 | 720,228 | |
| 11/13/2024 | 32.58 | 32.78 | 30.95 | 30.97 | 543,755 | |
| 11/12/2024 | 32.80 | 34.54 | 31.96 | 32.38 | 676,160 | |
| 11/11/2024 | 34.77 | 35.11 | 32.70 | 33.04 | 609,852 | |
| 11/08/2024 | 34.73 | 34.73 | 33.35 | 34.45 | 811,496 | |
| 11/07/2024 | 35.26 | 35.88 | 34.56 | 34.87 | 589,957 | |
| 11/06/2024 | 34.04 | 35.71 | 33.46 | 35.28 | 840,496 | |
| 11/05/2024 | 31.76 | 32.75 | 31.12 | 32.74 | 463,982 | |
| 11/04/2024 | 32.20 | 32.93 | 31.50 | 32.05 | 641,039 | |
| 11/01/2024 | 31.89 | 32.95 | 30.90 | 32.33 | 1,277,374 | |
| 10/31/2024 | 30.55 | 31.43 | 30.13 | 30.83 | 338,868 | |
| 10/30/2024 | 31.52 | 32.70 | 30.69 | 30.70 | 641,150 | |
| 10/29/2024 | 29.64 | 32.22 | 29.34 | 31.73 | 724,263 | |
| 10/28/2024 | 29.88 | 30.83 | 29.48 | 29.71 | 386,272 | |
| 10/25/2024 | 29.15 | 29.87 | 28.96 | 29.33 | 403,229 | |
| 10/24/2024 | 28.89 | 29.19 | 28.39 | 28.75 | 279,029 | |
| 10/23/2024 | 29.53 | 29.97 | 28.42 | 28.67 | 472,757 | |
| 10/22/2024 | 30.55 | 31.04 | 29.57 | 29.59 | 339,491 | |
| 10/21/2024 | 30.95 | 31.12 | 30.31 | 30.90 | 484,466 | |
| 10/18/2024 | 30.84 | 32.15 | 30.72 | 31.23 | 484,151 | |
| 10/17/2024 | 31.04 | 31.26 | 30.37 | 30.82 | 384,300 | |
| 10/16/2024 | 29.82 | 31.25 | 29.82 | 31.05 | 519,710 | |
| 10/15/2024 | 30.23 | 31.00 | 29.92 | 29.93 | 730,019 | |
| 10/14/2024 | 29.47 | 30.43 | 29.10 | 30.01 | 724,404 | |
| 10/11/2024 | 29.01 | 29.78 | 28.93 | 29.63 | 281,768 | |
| 10/10/2024 | 28.13 | 29.16 | 27.91 | 29.08 | 351,343 | |
| 10/09/2024 | 28.16 | 28.52 | 27.48 | 28.51 | 328,562 | |
| 10/08/2024 | 27.04 | 29.01 | 26.82 | 28.15 | 517,905 | |
| 10/07/2024 | 28.38 | 28.44 | 26.46 | 26.75 | 436,995 | |
| 10/04/2024 | 27.93 | 29.04 | 27.90 | 28.24 | 544,317 | |
| 10/03/2024 | 29.09 | 29.66 | 27.62 | 27.65 | 551,396 | |
| 10/02/2024 | 28.58 | 29.50 | 28.19 | 29.21 | 368,489 | |
| 10/01/2024 | 28.51 | 28.88 | 27.65 | 28.83 | 634,760 | |
| 09/30/2024 | 27.85 | 29.11 | 27.85 | 28.69 | 509,317 | |
| 09/27/2024 | 29.87 | 29.87 | 28.17 | 28.24 | 661,185 | |
| 09/26/2024 | 28.41 | 29.60 | 28.14 | 29.34 | 701,802 | |
| 09/25/2024 | 28.16 | 28.27 | 27.47 | 28.00 | 445,913 | |
| 09/24/2024 | 28.37 | 28.57 | 27.69 | 28.05 | 474,224 | |
| 09/23/2024 | 28.20 | 28.38 | 27.53 | 28.37 | 474,393 | |
| 09/20/2024 | 27.85 | 28.12 | 27.25 | 28.08 | 1,529,464 | |
| 09/19/2024 | 28.00 | 28.74 | 27.19 | 28.00 | 471,650 | |
| 09/18/2024 | 26.72 | 27.81 | 26.26 | 26.96 | 485,803 | |
| 09/17/2024 | 27.00 | 27.65 | 26.52 | 26.64 | 353,516 | |
| 09/16/2024 | 27.40 | 27.69 | 26.73 | 26.77 | 386,845 | |
| 09/13/2024 | 26.00 | 27.41 | 25.69 | 27.34 | 450,940 | |
| 09/12/2024 | 25.69 | 25.84 | 25.20 | 25.70 | 416,633 | |
| 09/11/2024 | 25.54 | 25.98 | 25.01 | 25.62 | 385,734 | |
| 09/10/2024 | 26.18 | 26.18 | 25.01 | 25.74 | 610,703 | |
| 09/09/2024 | 26.55 | 27.20 | 25.89 | 26.30 | 363,349 | |
| 09/06/2024 | 26.56 | 26.96 | 25.67 | 26.41 | 446,533 | |
| 09/05/2024 | 26.40 | 26.43 | 25.73 | 26.35 | 444,088 | |
| 09/04/2024 | 25.71 | 26.41 | 25.31 | 26.30 | 197,361 | |
| 09/03/2024 | 27.16 | 28.30 | 25.96 | 25.99 | 429,103 | |
| 08/30/2024 | 26.95 | 27.50 | 26.32 | 27.20 | 484,541 | |
| 08/29/2024 | 26.98 | 27.45 | 26.39 | 26.89 | 360,848 |
About Akero Therapeutics Stock history
Akero Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Akero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Akero Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Akero Therapeutics stock prices may prove useful in developing a viable investing in Akero Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 52.6 M | 34.6 M | |
| Net Loss | -100.8 M | -105.9 M |
Akero Therapeutics Quarterly Net Working Capital |
|
Akero Therapeutics Stock Technical Analysis
Akero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Akero Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Akero Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Akero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Akero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0826 | |||
| Jensen Alpha | 0.0923 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0649 | |||
| Treynor Ratio | 0.1454 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akero Therapeutics. If investors know Akero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.78) | Return On Assets (0.23) | Return On Equity (0.36) |
The market value of Akero Therapeutics is measured differently than its book value, which is the value of Akero that is recorded on the company's balance sheet. Investors also form their own opinion of Akero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akero Therapeutics' market value can be influenced by many factors that don't directly affect Akero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.